CD8A and neoplasm: In terms of chemoimmunotherapy, the tumour microenvironment was remodelled away from immunosuppression, including increased numbers of cytotoxic CD8+ T lymphocytes and M1-like TAMs and decreased numbers of Tregs and M2-like TAMs, all of which predicted favourable therapeutic responses.